Carlsmed, Inc.
CARL
$13.74
$0.141.03%
NASDAQ
| 06/30/2025 | |||||
|---|---|---|---|---|---|
| Revenue | 18.59% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 18.59% | ||||
| Cost of Revenue | 25.89% | ||||
| Gross Profit | 16.15% | ||||
| SG&A Expenses | 9.86% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 16.83% | ||||
| Operating Income | -13.69% | ||||
| Income Before Tax | -18.10% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -18.10% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -18.10% | ||||
| EBIT | -13.69% | ||||
| EBITDA | -13.42% | ||||
| EPS Basic | -0.40% | ||||
| Normalized Basic EPS | -10.64% | ||||
| EPS Diluted | -0.40% | ||||
| Normalized Diluted EPS | -10.64% | ||||
| Average Basic Shares Outstanding | 6.75% | ||||
| Average Diluted Shares Outstanding | 6.75% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||